CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Boceprevir

Last Updated: February 19, 2013
Result type: Reports
Project Number: SF0312
Product Line: Reimbursement Review

Generic Name: Boceprevir

Brand Name: Victrelis

Manufacturer: Merck Canada Inc.

Indications: Hepatitis C infection, chronic

Submission Type: Request For Advice

Project Status: Complete

Date Recommendation Issued: June 13, 2013

Recommendation Type: List with criteria/condition